nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—epilepsy syndrome	0.266	0.551	CbGaD
Vigabatrin—ABAT—Valproic Acid—epilepsy syndrome	0.232	1	CbGbCtD
Vigabatrin—ABAT—epilepsy syndrome	0.217	0.449	CbGaD
Vigabatrin—SLC36A1—hindbrain—epilepsy syndrome	0.00246	0.088	CbGeAlD
Vigabatrin—ABAT—hindbrain—epilepsy syndrome	0.00244	0.0874	CbGeAlD
Vigabatrin—GABBR1—telencephalon—epilepsy syndrome	0.00159	0.057	CbGeAlD
Vigabatrin—L-Glutamine—QARS—epilepsy syndrome	0.00147	0.672	CrCbGaD
Vigabatrin—SLC36A1—brainstem—epilepsy syndrome	0.00141	0.0504	CbGeAlD
Vigabatrin—ABAT—brainstem—epilepsy syndrome	0.0014	0.0501	CbGeAlD
Vigabatrin—ABAT—forebrain—epilepsy syndrome	0.00135	0.0483	CbGeAlD
Vigabatrin—GABBR1—medulla oblongata—epilepsy syndrome	0.00125	0.0447	CbGeAlD
Vigabatrin—SLC36A1—telencephalon—epilepsy syndrome	0.00125	0.0447	CbGeAlD
Vigabatrin—ABAT—telencephalon—epilepsy syndrome	0.00124	0.0445	CbGeAlD
Vigabatrin—GABBR1—midbrain—epilepsy syndrome	0.00114	0.0409	CbGeAlD
Vigabatrin—GABBR1—spinal cord—epilepsy syndrome	0.00111	0.0399	CbGeAlD
Vigabatrin—ABAT—medulla oblongata—epilepsy syndrome	0.000975	0.0349	CbGeAlD
Vigabatrin—ABAT—midbrain—epilepsy syndrome	0.000891	0.0319	CbGeAlD
Vigabatrin—GABBR1—cerebellum—epilepsy syndrome	0.000883	0.0316	CbGeAlD
Vigabatrin—ABAT—spinal cord—epilepsy syndrome	0.00087	0.0312	CbGeAlD
Vigabatrin—SLC36A1—head—epilepsy syndrome	0.000778	0.0279	CbGeAlD
Vigabatrin—ABAT—head—epilepsy syndrome	0.000773	0.0277	CbGeAlD
Vigabatrin—SLC36A1—nervous system—epilepsy syndrome	0.000737	0.0264	CbGeAlD
Vigabatrin—ABAT—nervous system—epilepsy syndrome	0.000733	0.0262	CbGeAlD
Vigabatrin—L-Glutamine—GLUL—epilepsy syndrome	0.000719	0.328	CrCbGaD
Vigabatrin—GABBR1—brain—epilepsy syndrome	0.000718	0.0257	CbGeAlD
Vigabatrin—SLC36A1—central nervous system—epilepsy syndrome	0.00071	0.0254	CbGeAlD
Vigabatrin—ABAT—central nervous system—epilepsy syndrome	0.000706	0.0253	CbGeAlD
Vigabatrin—SLC36A1—cerebellum—epilepsy syndrome	0.000694	0.0249	CbGeAlD
Vigabatrin—ABAT—cerebellum—epilepsy syndrome	0.00069	0.0247	CbGeAlD
Vigabatrin—SLC36A1—brain—epilepsy syndrome	0.000564	0.0202	CbGeAlD
Vigabatrin—ABAT—brain—epilepsy syndrome	0.00056	0.0201	CbGeAlD
Vigabatrin—GABBR1—Signaling by GPCR—ACKR4—epilepsy syndrome	6.68e-05	0.000698	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SSTR4—epilepsy syndrome	6.66e-05	0.000695	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SSTR5—epilepsy syndrome	6.66e-05	0.000695	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—BCHE—epilepsy syndrome	6.58e-05	0.000687	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CX3CR1—epilepsy syndrome	6.49e-05	0.000677	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	6.48e-05	0.000677	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	6.42e-05	0.000671	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—DLG4—epilepsy syndrome	6.42e-05	0.000671	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR10—epilepsy syndrome	6.38e-05	0.000666	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—BDKRB1—epilepsy syndrome	6.36e-05	0.000664	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CHRM2—epilepsy syndrome	6.36e-05	0.000664	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CX3CL1—epilepsy syndrome	6.36e-05	0.000664	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	6.33e-05	0.000661	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—GRIN2B—epilepsy syndrome	6.28e-05	0.000655	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—PLCB1—epilepsy syndrome	6.21e-05	0.000648	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	6.16e-05	0.000643	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—SSTR5—epilepsy syndrome	6.05e-05	0.000631	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—SSTR4—epilepsy syndrome	6.05e-05	0.000631	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—HRH3—epilepsy syndrome	5.93e-05	0.000619	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	5.93e-05	0.000619	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	5.92e-05	0.000618	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—OPRM1—epilepsy syndrome	5.84e-05	0.00061	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR10—epilepsy syndrome	5.8e-05	0.000605	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	5.73e-05	0.000598	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	5.73e-05	0.000598	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	5.73e-05	0.000598	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM2—epilepsy syndrome	5.58e-05	0.000582	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCR3—epilepsy syndrome	5.52e-05	0.000576	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	5.49e-05	0.000573	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—NPY—epilepsy syndrome	5.37e-05	0.000561	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCL3—epilepsy syndrome	5.19e-05	0.000541	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CRH—epilepsy syndrome	5.19e-05	0.000541	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—OXT—epilepsy syndrome	5.19e-05	0.000541	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL2—epilepsy syndrome	5.19e-05	0.000541	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.1e-05	0.000533	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM2—epilepsy syndrome	5.07e-05	0.000529	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SSTR3—epilepsy syndrome	5.04e-05	0.000527	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCR5—epilepsy syndrome	4.99e-05	0.000521	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	4.87e-05	0.000509	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	4.84e-05	0.000505	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR8—epilepsy syndrome	4.84e-05	0.000505	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SSTR1—epilepsy syndrome	4.84e-05	0.000505	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR9—epilepsy syndrome	4.84e-05	0.000505	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—NPY2R—epilepsy syndrome	4.84e-05	0.000505	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM3—epilepsy syndrome	4.74e-05	0.000495	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM4—epilepsy syndrome	4.74e-05	0.000495	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCR2—epilepsy syndrome	4.69e-05	0.00049	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—SST—epilepsy syndrome	4.69e-05	0.00049	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	4.67e-05	0.000487	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SSTR2—epilepsy syndrome	4.66e-05	0.000486	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—AGT—epilepsy syndrome	4.63e-05	0.000484	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRA2A—epilepsy syndrome	4.59e-05	0.000479	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—SSTR3—epilepsy syndrome	4.58e-05	0.000478	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.55e-05	0.000475	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRICKLE1—epilepsy syndrome	4.52e-05	0.000472	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRDM4—epilepsy syndrome	4.52e-05	0.000472	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM8—epilepsy syndrome	4.5e-05	0.000469	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL12—epilepsy syndrome	4.41e-05	0.00046	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—BDKRB2—epilepsy syndrome	4.41e-05	0.00046	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NPY2R—epilepsy syndrome	4.39e-05	0.000459	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR8—epilepsy syndrome	4.39e-05	0.000459	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	4.39e-05	0.000459	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR9—epilepsy syndrome	4.39e-05	0.000459	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—SSTR1—epilepsy syndrome	4.39e-05	0.000459	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—PRKCB—epilepsy syndrome	4.39e-05	0.000458	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CNR1—epilepsy syndrome	4.33e-05	0.000452	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM3—epilepsy syndrome	4.31e-05	0.00045	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM4—epilepsy syndrome	4.31e-05	0.00045	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—OPRD1—epilepsy syndrome	4.29e-05	0.000448	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—SSTR2—epilepsy syndrome	4.23e-05	0.000441	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—HTR7—epilepsy syndrome	4.22e-05	0.000441	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PDYN—epilepsy syndrome	4.11e-05	0.000429	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR7—epilepsy syndrome	4.11e-05	0.000429	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CHRM1—epilepsy syndrome	4.11e-05	0.000429	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM1—epilepsy syndrome	4.11e-05	0.000429	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM8—epilepsy syndrome	4.08e-05	0.000426	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ACKR4—epilepsy syndrome	3.95e-05	0.000412	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—POMC—epilepsy syndrome	3.9e-05	0.000407	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GNAO1—epilepsy syndrome	3.9e-05	0.000407	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—OPRD1—epilepsy syndrome	3.9e-05	0.000407	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.87e-05	0.000404	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GAL—epilepsy syndrome	3.87e-05	0.000404	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CHRM3—epilepsy syndrome	3.82e-05	0.000399	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM5—epilepsy syndrome	3.82e-05	0.000399	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR7—epilepsy syndrome	3.73e-05	0.00039	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PDYN—epilepsy syndrome	3.73e-05	0.00039	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CHRM1—epilepsy syndrome	3.73e-05	0.00039	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM1—epilepsy syndrome	3.73e-05	0.00039	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—PRKCB—epilepsy syndrome	3.73e-05	0.00039	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.69e-05	0.000385	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	3.59e-05	0.000375	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CHRM2—epilepsy syndrome	3.59e-05	0.000375	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	3.59e-05	0.000374	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SSTR4—epilepsy syndrome	3.57e-05	0.000373	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SSTR5—epilepsy syndrome	3.57e-05	0.000373	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AVP—epilepsy syndrome	3.55e-05	0.000371	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GAL—epilepsy syndrome	3.51e-05	0.000367	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM5—epilepsy syndrome	3.47e-05	0.000363	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CHRM3—epilepsy syndrome	3.47e-05	0.000363	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR10—epilepsy syndrome	3.42e-05	0.000357	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HRH3—epilepsy syndrome	3.35e-05	0.00035	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CX3CR1—epilepsy syndrome	3.33e-05	0.000348	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—OPRM1—epilepsy syndrome	3.3e-05	0.000345	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—BDKRB1—epilepsy syndrome	3.26e-05	0.000341	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CHRM2—epilepsy syndrome	3.26e-05	0.000341	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CX3CL1—epilepsy syndrome	3.26e-05	0.000341	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR3—epilepsy syndrome	3.12e-05	0.000325	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HRH3—epilepsy syndrome	3.04e-05	0.000318	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—NPY—epilepsy syndrome	3.04e-05	0.000317	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.04e-05	0.000317	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCR5—epilepsy syndrome	3.02e-05	0.000316	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.01e-05	0.000314	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—OPRM1—epilepsy syndrome	3e-05	0.000313	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GRM2—epilepsy syndrome	2.99e-05	0.000312	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—HTR2A—epilepsy syndrome	2.96e-05	0.000309	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—OXT—epilepsy syndrome	2.93e-05	0.000306	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CRH—epilepsy syndrome	2.93e-05	0.000306	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	2.93e-05	0.000306	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.91e-05	0.000304	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR3—epilepsy syndrome	2.83e-05	0.000296	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AGT—epilepsy syndrome	2.81e-05	0.000293	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NPY—epilepsy syndrome	2.76e-05	0.000288	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SSTR3—epilepsy syndrome	2.71e-05	0.000283	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CRH—epilepsy syndrome	2.66e-05	0.000278	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—OXT—epilepsy syndrome	2.66e-05	0.000278	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL3—epilepsy syndrome	2.66e-05	0.000278	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL2—epilepsy syndrome	2.66e-05	0.000278	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR2—epilepsy syndrome	2.65e-05	0.000277	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SST—epilepsy syndrome	2.65e-05	0.000277	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	2.65e-05	0.000277	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	2.59e-05	0.000271	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SSTR1—epilepsy syndrome	2.59e-05	0.000271	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR9—epilepsy syndrome	2.59e-05	0.000271	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR8—epilepsy syndrome	2.59e-05	0.000271	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NPY2R—epilepsy syndrome	2.59e-05	0.000271	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	2.59e-05	0.000271	CbGpPWpGaD
Vigabatrin—Vomiting—Fosphenytoin—epilepsy syndrome	2.58e-05	0.000163	CcSEcCtD
Vigabatrin—Diarrhoea—Felbamate—epilepsy syndrome	2.58e-05	0.000163	CcSEcCtD
Vigabatrin—Vertigo—Pregabalin—epilepsy syndrome	2.58e-05	0.000162	CcSEcCtD
Vigabatrin—Body temperature increased—Lamotrigine—epilepsy syndrome	2.58e-05	0.000162	CcSEcCtD
Vigabatrin—Abdominal pain—Lamotrigine—epilepsy syndrome	2.58e-05	0.000162	CcSEcCtD
Vigabatrin—Dizziness—Diazepam—epilepsy syndrome	2.58e-05	0.000162	CcSEcCtD
Vigabatrin—Infection—Valproic Acid—epilepsy syndrome	2.58e-05	0.000162	CcSEcCtD
Vigabatrin—Rash—Fosphenytoin—epilepsy syndrome	2.56e-05	0.000161	CcSEcCtD
Vigabatrin—Dermatitis—Fosphenytoin—epilepsy syndrome	2.56e-05	0.000161	CcSEcCtD
Vigabatrin—Nervousness—Gabapentin—epilepsy syndrome	2.56e-05	0.000161	CcSEcCtD
Vigabatrin—Asthenia—Clonazepam—epilepsy syndrome	2.55e-05	0.000161	CcSEcCtD
Vigabatrin—Back pain—Gabapentin—epilepsy syndrome	2.55e-05	0.00016	CcSEcCtD
Vigabatrin—Headache—Fosphenytoin—epilepsy syndrome	2.55e-05	0.00016	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GRM4—epilepsy syndrome	2.54e-05	0.000266	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GRM3—epilepsy syndrome	2.54e-05	0.000266	CbGpPWpGaD
Vigabatrin—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.54e-05	0.00016	CcSEcCtD
Vigabatrin—Asthenia—Phenytoin—epilepsy syndrome	2.54e-05	0.00016	CcSEcCtD
Vigabatrin—Nausea—Midazolam—epilepsy syndrome	2.53e-05	0.000159	CcSEcCtD
Vigabatrin—Hypoaesthesia—Topiramate—epilepsy syndrome	2.53e-05	0.000159	CcSEcCtD
Vigabatrin—Hallucination—Topiramate—epilepsy syndrome	2.53e-05	0.000159	CcSEcCtD
Vigabatrin—Muscle spasms—Gabapentin—epilepsy syndrome	2.53e-05	0.000159	CcSEcCtD
Vigabatrin—Diarrhoea—Zonisamide—epilepsy syndrome	2.53e-05	0.000159	CcSEcCtD
Vigabatrin—Asthenia—Oxcarbazepine—epilepsy syndrome	2.52e-05	0.000159	CcSEcCtD
Vigabatrin—Pruritus—Clonazepam—epilepsy syndrome	2.52e-05	0.000159	CcSEcCtD
Vigabatrin—Skin disorder—Valproic Acid—epilepsy syndrome	2.52e-05	0.000158	CcSEcCtD
Vigabatrin—Oedema peripheral—Topiramate—epilepsy syndrome	2.51e-05	0.000158	CcSEcCtD
Vigabatrin—Cough—Pregabalin—epilepsy syndrome	2.51e-05	0.000158	CcSEcCtD
Vigabatrin—Pruritus—Phenytoin—epilepsy syndrome	2.5e-05	0.000157	CcSEcCtD
Vigabatrin—Connective tissue disorder—Topiramate—epilepsy syndrome	2.5e-05	0.000157	CcSEcCtD
Vigabatrin—Nausea—Levetiracetam—epilepsy syndrome	2.5e-05	0.000157	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—DUSP4—epilepsy syndrome	2.5e-05	0.000261	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SSTR2—epilepsy syndrome	2.5e-05	0.000261	CbGpPWpGaD
Vigabatrin—Dizziness—Felbamate—epilepsy syndrome	2.5e-05	0.000157	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	2.49e-05	0.00026	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	2.49e-05	0.00026	CbGpPWpGaD
Vigabatrin—Pruritus—Oxcarbazepine—epilepsy syndrome	2.49e-05	0.000157	CcSEcCtD
Vigabatrin—Convulsion—Pregabalin—epilepsy syndrome	2.49e-05	0.000157	CcSEcCtD
Vigabatrin—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.49e-05	0.000157	CcSEcCtD
Vigabatrin—Vision blurred—Gabapentin—epilepsy syndrome	2.48e-05	0.000156	CcSEcCtD
Vigabatrin—Vomiting—Diazepam—epilepsy syndrome	2.48e-05	0.000156	CcSEcCtD
Vigabatrin—Tremor—Gabapentin—epilepsy syndrome	2.47e-05	0.000155	CcSEcCtD
Vigabatrin—Rash—Diazepam—epilepsy syndrome	2.46e-05	0.000155	CcSEcCtD
Vigabatrin—Dermatitis—Diazepam—epilepsy syndrome	2.46e-05	0.000155	CcSEcCtD
Vigabatrin—Visual impairment—Topiramate—epilepsy syndrome	2.45e-05	0.000154	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CNR1—epilepsy syndrome	2.45e-05	0.000255	CbGpPWpGaD
Vigabatrin—Chest pain—Pregabalin—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Vigabatrin—Myalgia—Pregabalin—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Vigabatrin—Arthralgia—Pregabalin—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Vigabatrin—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Vigabatrin—Dizziness—Zonisamide—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Vigabatrin—Headache—Diazepam—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	2.44e-05	0.000254	CbGpPWpGaD
Vigabatrin—Anxiety—Pregabalin—epilepsy syndrome	2.44e-05	0.000153	CcSEcCtD
Vigabatrin—Diarrhoea—Clonazepam—epilepsy syndrome	2.44e-05	0.000153	CcSEcCtD
Vigabatrin—Anaemia—Gabapentin—epilepsy syndrome	2.43e-05	0.000153	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.43e-05	0.000153	CcSEcCtD
Vigabatrin—Asthenia—Carbamazepine—epilepsy syndrome	2.42e-05	0.000152	CcSEcCtD
Vigabatrin—Agitation—Gabapentin—epilepsy syndrome	2.42e-05	0.000152	CcSEcCtD
Vigabatrin—Diarrhoea—Phenytoin—epilepsy syndrome	2.42e-05	0.000152	CcSEcCtD
Vigabatrin—Discomfort—Pregabalin—epilepsy syndrome	2.42e-05	0.000152	CcSEcCtD
Vigabatrin—Nausea—Fosphenytoin—epilepsy syndrome	2.41e-05	0.000152	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GRM8—epilepsy syndrome	2.41e-05	0.000252	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PGF—epilepsy syndrome	2.41e-05	0.000252	CbGpPWpGaD
Vigabatrin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.41e-05	0.000151	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—SST—epilepsy syndrome	2.41e-05	0.000251	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR2—epilepsy syndrome	2.41e-05	0.000251	CbGpPWpGaD
Vigabatrin—Erythema multiforme—Topiramate—epilepsy syndrome	2.41e-05	0.000151	CcSEcCtD
Vigabatrin—Angioedema—Gabapentin—epilepsy syndrome	2.41e-05	0.000151	CcSEcCtD
Vigabatrin—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.4e-05	0.000151	CcSEcCtD
Vigabatrin—Vomiting—Felbamate—epilepsy syndrome	2.4e-05	0.000151	CcSEcCtD
Vigabatrin—Pruritus—Carbamazepine—epilepsy syndrome	2.39e-05	0.00015	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—HTR7—epilepsy syndrome	2.39e-05	0.000249	CbGpPWpGaD
Vigabatrin—Rash—Felbamate—epilepsy syndrome	2.38e-05	0.00015	CcSEcCtD
Vigabatrin—Eye disorder—Topiramate—epilepsy syndrome	2.38e-05	0.00015	CcSEcCtD
Vigabatrin—Dermatitis—Felbamate—epilepsy syndrome	2.38e-05	0.00015	CcSEcCtD
Vigabatrin—Malaise—Gabapentin—epilepsy syndrome	2.37e-05	0.000149	CcSEcCtD
Vigabatrin—Tinnitus—Topiramate—epilepsy syndrome	2.37e-05	0.000149	CcSEcCtD
Vigabatrin—Vertigo—Gabapentin—epilepsy syndrome	2.37e-05	0.000149	CcSEcCtD
Vigabatrin—Headache—Felbamate—epilepsy syndrome	2.36e-05	0.000149	CcSEcCtD
Vigabatrin—Confusional state—Pregabalin—epilepsy syndrome	2.36e-05	0.000149	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.36e-05	0.000149	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—POMC—epilepsy syndrome	2.36e-05	0.000247	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.36e-05	0.000246	CbGpPWpGaD
Vigabatrin—Dizziness—Clonazepam—epilepsy syndrome	2.35e-05	0.000148	CcSEcCtD
Vigabatrin—Vomiting—Zonisamide—epilepsy syndrome	2.35e-05	0.000148	CcSEcCtD
Vigabatrin—Insomnia—Valproic Acid—epilepsy syndrome	2.34e-05	0.000148	CcSEcCtD
Vigabatrin—Oedema—Pregabalin—epilepsy syndrome	2.34e-05	0.000148	CcSEcCtD
Vigabatrin—Asthenia—Lamotrigine—epilepsy syndrome	2.34e-05	0.000147	CcSEcCtD
Vigabatrin—Dizziness—Phenytoin—epilepsy syndrome	2.34e-05	0.000147	CcSEcCtD
Vigabatrin—Rash—Zonisamide—epilepsy syndrome	2.33e-05	0.000147	CcSEcCtD
Vigabatrin—Infection—Pregabalin—epilepsy syndrome	2.33e-05	0.000147	CcSEcCtD
Vigabatrin—Paraesthesia—Valproic Acid—epilepsy syndrome	2.33e-05	0.000147	CcSEcCtD
Vigabatrin—Dermatitis—Zonisamide—epilepsy syndrome	2.33e-05	0.000146	CcSEcCtD
Vigabatrin—Dizziness—Oxcarbazepine—epilepsy syndrome	2.33e-05	0.000146	CcSEcCtD
Vigabatrin—Nausea—Diazepam—epilepsy syndrome	2.32e-05	0.000146	CcSEcCtD
Vigabatrin—Headache—Zonisamide—epilepsy syndrome	2.31e-05	0.000146	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCL2—epilepsy syndrome	2.31e-05	0.000241	CbGpPWpGaD
Vigabatrin—Diarrhoea—Carbamazepine—epilepsy syndrome	2.31e-05	0.000145	CcSEcCtD
Vigabatrin—Pruritus—Lamotrigine—epilepsy syndrome	2.31e-05	0.000145	CcSEcCtD
Vigabatrin—Somnolence—Valproic Acid—epilepsy syndrome	2.3e-05	0.000145	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GNAO1—epilepsy syndrome	2.3e-05	0.00024	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—OPRD1—epilepsy syndrome	2.3e-05	0.00024	CbGpPWpGaD
Vigabatrin—Nervous system disorder—Pregabalin—epilepsy syndrome	2.3e-05	0.000145	CcSEcCtD
Vigabatrin—Cough—Gabapentin—epilepsy syndrome	2.3e-05	0.000145	CcSEcCtD
Vigabatrin—Dyspepsia—Valproic Acid—epilepsy syndrome	2.28e-05	0.000144	CcSEcCtD
Vigabatrin—Convulsion—Gabapentin—epilepsy syndrome	2.28e-05	0.000144	CcSEcCtD
Vigabatrin—Skin disorder—Pregabalin—epilepsy syndrome	2.28e-05	0.000143	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT3—epilepsy syndrome	2.27e-05	0.000237	CbGpPWpGaD
Vigabatrin—Vomiting—Clonazepam—epilepsy syndrome	2.26e-05	0.000142	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.26e-05	0.000236	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL12—epilepsy syndrome	2.26e-05	0.000236	CbGpPWpGaD
Vigabatrin—Decreased appetite—Valproic Acid—epilepsy syndrome	2.25e-05	0.000142	CcSEcCtD
Vigabatrin—Vomiting—Phenytoin—epilepsy syndrome	2.25e-05	0.000142	CcSEcCtD
Vigabatrin—Rash—Clonazepam—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Dermatitis—Clonazepam—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Myalgia—Gabapentin—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Arthralgia—Gabapentin—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Chest pain—Gabapentin—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Nausea—Felbamate—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Vomiting—Oxcarbazepine—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Fatigue—Valproic Acid—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Vigabatrin—Anxiety—Gabapentin—epilepsy syndrome	2.23e-05	0.000141	CcSEcCtD
Vigabatrin—Dizziness—Carbamazepine—epilepsy syndrome	2.23e-05	0.00014	CcSEcCtD
Vigabatrin—Diarrhoea—Lamotrigine—epilepsy syndrome	2.23e-05	0.00014	CcSEcCtD
Vigabatrin—Headache—Clonazepam—epilepsy syndrome	2.23e-05	0.00014	CcSEcCtD
Vigabatrin—Rash—Phenytoin—epilepsy syndrome	2.23e-05	0.00014	CcSEcCtD
Vigabatrin—Mental disorder—Topiramate—epilepsy syndrome	2.23e-05	0.00014	CcSEcCtD
Vigabatrin—Dermatitis—Phenytoin—epilepsy syndrome	2.23e-05	0.00014	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.23e-05	0.00014	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CNR1—epilepsy syndrome	2.22e-05	0.000232	CbGpPWpGaD
Vigabatrin—Rash—Oxcarbazepine—epilepsy syndrome	2.22e-05	0.00014	CcSEcCtD
Vigabatrin—Constipation—Valproic Acid—epilepsy syndrome	2.22e-05	0.00014	CcSEcCtD
Vigabatrin—Pain—Valproic Acid—epilepsy syndrome	2.22e-05	0.00014	CcSEcCtD
Vigabatrin—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.22e-05	0.000139	CcSEcCtD
Vigabatrin—Headache—Phenytoin—epilepsy syndrome	2.22e-05	0.000139	CcSEcCtD
Vigabatrin—Malnutrition—Topiramate—epilepsy syndrome	2.22e-05	0.000139	CcSEcCtD
Vigabatrin—Discomfort—Gabapentin—epilepsy syndrome	2.22e-05	0.000139	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.21e-05	0.000231	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CHRM1—epilepsy syndrome	2.21e-05	0.00023	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PDYN—epilepsy syndrome	2.21e-05	0.00023	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GRM1—epilepsy syndrome	2.21e-05	0.00023	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR7—epilepsy syndrome	2.21e-05	0.00023	CbGpPWpGaD
Vigabatrin—Headache—Oxcarbazepine—epilepsy syndrome	2.2e-05	0.000139	CcSEcCtD
Vigabatrin—Nausea—Zonisamide—epilepsy syndrome	2.19e-05	0.000138	CcSEcCtD
Vigabatrin—Tension—Topiramate—epilepsy syndrome	2.17e-05	0.000137	CcSEcCtD
Vigabatrin—Confusional state—Gabapentin—epilepsy syndrome	2.17e-05	0.000136	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—HTR7—epilepsy syndrome	2.17e-05	0.000226	CbGpPWpGaD
Vigabatrin—Dizziness—Lamotrigine—epilepsy syndrome	2.16e-05	0.000136	CcSEcCtD
Vigabatrin—Nervousness—Topiramate—epilepsy syndrome	2.15e-05	0.000135	CcSEcCtD
Vigabatrin—Oedema—Gabapentin—epilepsy syndrome	2.15e-05	0.000135	CcSEcCtD
Vigabatrin—Vomiting—Carbamazepine—epilepsy syndrome	2.15e-05	0.000135	CcSEcCtD
Vigabatrin—Back pain—Topiramate—epilepsy syndrome	2.14e-05	0.000135	CcSEcCtD
Vigabatrin—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.14e-05	0.000134	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.14e-05	0.000134	CcSEcCtD
Vigabatrin—Infection—Gabapentin—epilepsy syndrome	2.14e-05	0.000134	CcSEcCtD
Vigabatrin—Muscle spasms—Topiramate—epilepsy syndrome	2.13e-05	0.000134	CcSEcCtD
Vigabatrin—Rash—Carbamazepine—epilepsy syndrome	2.13e-05	0.000134	CcSEcCtD
Vigabatrin—Dermatitis—Carbamazepine—epilepsy syndrome	2.13e-05	0.000134	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.12e-05	0.000133	CcSEcCtD
Vigabatrin—Insomnia—Pregabalin—epilepsy syndrome	2.12e-05	0.000133	CcSEcCtD
Vigabatrin—Nausea—Clonazepam—epilepsy syndrome	2.11e-05	0.000133	CcSEcCtD
Vigabatrin—Headache—Carbamazepine—epilepsy syndrome	2.11e-05	0.000133	CcSEcCtD
Vigabatrin—Nervous system disorder—Gabapentin—epilepsy syndrome	2.11e-05	0.000133	CcSEcCtD
Vigabatrin—Paraesthesia—Pregabalin—epilepsy syndrome	2.1e-05	0.000132	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.1e-05	0.00022	CbGpPWpGaD
Vigabatrin—Nausea—Phenytoin—epilepsy syndrome	2.1e-05	0.000132	CcSEcCtD
Vigabatrin—Nausea—Oxcarbazepine—epilepsy syndrome	2.09e-05	0.000132	CcSEcCtD
Vigabatrin—Vision blurred—Topiramate—epilepsy syndrome	2.09e-05	0.000131	CcSEcCtD
Vigabatrin—Skin disorder—Gabapentin—epilepsy syndrome	2.09e-05	0.000131	CcSEcCtD
Vigabatrin—Somnolence—Pregabalin—epilepsy syndrome	2.08e-05	0.000131	CcSEcCtD
Vigabatrin—Tremor—Topiramate—epilepsy syndrome	2.08e-05	0.000131	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.07e-05	0.000217	CbGpPWpGaD
Vigabatrin—Vomiting—Lamotrigine—epilepsy syndrome	2.07e-05	0.000131	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GFAP—epilepsy syndrome	2.07e-05	0.000217	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GAL—epilepsy syndrome	2.07e-05	0.000217	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT3—epilepsy syndrome	2.06e-05	0.000216	CbGpPWpGaD
Vigabatrin—Urticaria—Valproic Acid—epilepsy syndrome	2.06e-05	0.00013	CcSEcCtD
Vigabatrin—Rash—Lamotrigine—epilepsy syndrome	2.06e-05	0.000129	CcSEcCtD
Vigabatrin—Ill-defined disorder—Topiramate—epilepsy syndrome	2.06e-05	0.000129	CcSEcCtD
Vigabatrin—Dermatitis—Lamotrigine—epilepsy syndrome	2.06e-05	0.000129	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CASP2—epilepsy syndrome	2.05e-05	0.000214	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CHRM3—epilepsy syndrome	2.05e-05	0.000214	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GRM5—epilepsy syndrome	2.05e-05	0.000214	CbGpPWpGaD
Vigabatrin—Abdominal pain—Valproic Acid—epilepsy syndrome	2.05e-05	0.000129	CcSEcCtD
Vigabatrin—Body temperature increased—Valproic Acid—epilepsy syndrome	2.05e-05	0.000129	CcSEcCtD
Vigabatrin—Anaemia—Topiramate—epilepsy syndrome	2.05e-05	0.000129	CcSEcCtD
Vigabatrin—Headache—Lamotrigine—epilepsy syndrome	2.04e-05	0.000129	CcSEcCtD
Vigabatrin—Decreased appetite—Pregabalin—epilepsy syndrome	2.04e-05	0.000128	CcSEcCtD
Vigabatrin—Agitation—Topiramate—epilepsy syndrome	2.04e-05	0.000128	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.02e-05	0.000127	CcSEcCtD
Vigabatrin—Fatigue—Pregabalin—epilepsy syndrome	2.02e-05	0.000127	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AVP—epilepsy syndrome	2.01e-05	0.00021	CbGpPWpGaD
Vigabatrin—Nausea—Carbamazepine—epilepsy syndrome	2.01e-05	0.000126	CcSEcCtD
Vigabatrin—Pain—Pregabalin—epilepsy syndrome	2e-05	0.000126	CcSEcCtD
Vigabatrin—Constipation—Pregabalin—epilepsy syndrome	2e-05	0.000126	CcSEcCtD
Vigabatrin—Malaise—Topiramate—epilepsy syndrome	2e-05	0.000126	CcSEcCtD
Vigabatrin—Vertigo—Topiramate—epilepsy syndrome	1.99e-05	0.000125	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.97e-05	0.000205	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.96e-05	0.000123	CcSEcCtD
Vigabatrin—Insomnia—Gabapentin—epilepsy syndrome	1.94e-05	0.000122	CcSEcCtD
Vigabatrin—Nausea—Lamotrigine—epilepsy syndrome	1.94e-05	0.000122	CcSEcCtD
Vigabatrin—Cough—Topiramate—epilepsy syndrome	1.93e-05	0.000122	CcSEcCtD
Vigabatrin—Feeling abnormal—Pregabalin—epilepsy syndrome	1.93e-05	0.000122	CcSEcCtD
Vigabatrin—Paraesthesia—Gabapentin—epilepsy syndrome	1.93e-05	0.000121	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.93e-05	0.000201	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.93e-05	0.000201	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CHRM2—epilepsy syndrome	1.93e-05	0.000201	CbGpPWpGaD
Vigabatrin—Convulsion—Topiramate—epilepsy syndrome	1.92e-05	0.000121	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.92e-05	0.000121	CcSEcCtD
Vigabatrin—Somnolence—Gabapentin—epilepsy syndrome	1.91e-05	0.00012	CcSEcCtD
Vigabatrin—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.91e-05	0.00012	CcSEcCtD
Vigabatrin—Dyspepsia—Gabapentin—epilepsy syndrome	1.89e-05	0.000119	CcSEcCtD
Vigabatrin—Myalgia—Topiramate—epilepsy syndrome	1.89e-05	0.000119	CcSEcCtD
Vigabatrin—Chest pain—Topiramate—epilepsy syndrome	1.89e-05	0.000119	CcSEcCtD
Vigabatrin—Arthralgia—Topiramate—epilepsy syndrome	1.89e-05	0.000119	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CDC42—epilepsy syndrome	1.88e-05	0.000197	CbGpPWpGaD
Vigabatrin—Anxiety—Topiramate—epilepsy syndrome	1.88e-05	0.000118	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.87e-05	0.000118	CcSEcCtD
Vigabatrin—Decreased appetite—Gabapentin—epilepsy syndrome	1.87e-05	0.000118	CcSEcCtD
Vigabatrin—Discomfort—Topiramate—epilepsy syndrome	1.86e-05	0.000117	CcSEcCtD
Vigabatrin—Urticaria—Pregabalin—epilepsy syndrome	1.86e-05	0.000117	CcSEcCtD
Vigabatrin—Asthenia—Valproic Acid—epilepsy syndrome	1.86e-05	0.000117	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.86e-05	0.000117	CcSEcCtD
Vigabatrin—Fatigue—Gabapentin—epilepsy syndrome	1.85e-05	0.000117	CcSEcCtD
Vigabatrin—Abdominal pain—Pregabalin—epilepsy syndrome	1.85e-05	0.000117	CcSEcCtD
Vigabatrin—Body temperature increased—Pregabalin—epilepsy syndrome	1.85e-05	0.000117	CcSEcCtD
Vigabatrin—Pain—Gabapentin—epilepsy syndrome	1.84e-05	0.000116	CcSEcCtD
Vigabatrin—Constipation—Gabapentin—epilepsy syndrome	1.84e-05	0.000116	CcSEcCtD
Vigabatrin—Pruritus—Valproic Acid—epilepsy syndrome	1.83e-05	0.000115	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—AVP—epilepsy syndrome	1.82e-05	0.00019	CbGpPWpGaD
Vigabatrin—Confusional state—Topiramate—epilepsy syndrome	1.82e-05	0.000115	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.82e-05	0.00019	CbGpPWpGaD
Vigabatrin—Oedema—Topiramate—epilepsy syndrome	1.81e-05	0.000114	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HRH3—epilepsy syndrome	1.8e-05	0.000188	CbGpPWpGaD
Vigabatrin—Infection—Topiramate—epilepsy syndrome	1.8e-05	0.000113	CcSEcCtD
Vigabatrin—Diarrhoea—Valproic Acid—epilepsy syndrome	1.77e-05	0.000112	CcSEcCtD
Vigabatrin—Nervous system disorder—Topiramate—epilepsy syndrome	1.77e-05	0.000112	CcSEcCtD
Vigabatrin—Feeling abnormal—Gabapentin—epilepsy syndrome	1.77e-05	0.000111	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—OPRM1—epilepsy syndrome	1.77e-05	0.000185	CbGpPWpGaD
Vigabatrin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.76e-05	0.000111	CcSEcCtD
Vigabatrin—Skin disorder—Topiramate—epilepsy syndrome	1.76e-05	0.000111	CcSEcCtD
Vigabatrin—Hypersensitivity—Pregabalin—epilepsy syndrome	1.73e-05	0.000109	CcSEcCtD
Vigabatrin—Dizziness—Valproic Acid—epilepsy syndrome	1.71e-05	0.000108	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.71e-05	0.000178	CbGpPWpGaD
Vigabatrin—Urticaria—Gabapentin—epilepsy syndrome	1.71e-05	0.000107	CcSEcCtD
Vigabatrin—Body temperature increased—Gabapentin—epilepsy syndrome	1.7e-05	0.000107	CcSEcCtD
Vigabatrin—Abdominal pain—Gabapentin—epilepsy syndrome	1.7e-05	0.000107	CcSEcCtD
Vigabatrin—Asthenia—Pregabalin—epilepsy syndrome	1.68e-05	0.000106	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CCR3—epilepsy syndrome	1.67e-05	0.000175	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.67e-05	0.000174	CbGpPWpGaD
Vigabatrin—Pruritus—Pregabalin—epilepsy syndrome	1.66e-05	0.000104	CcSEcCtD
Vigabatrin—Vomiting—Valproic Acid—epilepsy syndrome	1.65e-05	0.000104	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.65e-05	0.000104	CcSEcCtD
Vigabatrin—Insomnia—Topiramate—epilepsy syndrome	1.64e-05	0.000103	CcSEcCtD
Vigabatrin—Rash—Valproic Acid—epilepsy syndrome	1.63e-05	0.000103	CcSEcCtD
Vigabatrin—Dermatitis—Valproic Acid—epilepsy syndrome	1.63e-05	0.000103	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—NPY—epilepsy syndrome	1.63e-05	0.00017	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.63e-05	0.00017	CbGpPWpGaD
Vigabatrin—Headache—Valproic Acid—epilepsy syndrome	1.62e-05	0.000102	CcSEcCtD
Vigabatrin—Paraesthesia—Topiramate—epilepsy syndrome	1.62e-05	0.000102	CcSEcCtD
Vigabatrin—Somnolence—Topiramate—epilepsy syndrome	1.61e-05	0.000101	CcSEcCtD
Vigabatrin—Diarrhoea—Pregabalin—epilepsy syndrome	1.6e-05	0.000101	CcSEcCtD
Vigabatrin—Dyspepsia—Topiramate—epilepsy syndrome	1.59e-05	0.0001	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AGT—epilepsy syndrome	1.59e-05	0.000166	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Gabapentin—epilepsy syndrome	1.58e-05	9.97e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HSPB1—epilepsy syndrome	1.57e-05	0.000164	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—OXT—epilepsy syndrome	1.57e-05	0.000164	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL2—epilepsy syndrome	1.57e-05	0.000164	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL3—epilepsy syndrome	1.57e-05	0.000164	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CRH—epilepsy syndrome	1.57e-05	0.000164	CbGpPWpGaD
Vigabatrin—Decreased appetite—Topiramate—epilepsy syndrome	1.57e-05	9.89e-05	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.56e-05	9.82e-05	CcSEcCtD
Vigabatrin—Fatigue—Topiramate—epilepsy syndrome	1.56e-05	9.81e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CCR5—epilepsy syndrome	1.55e-05	0.000162	CbGpPWpGaD
Vigabatrin—Dizziness—Pregabalin—epilepsy syndrome	1.55e-05	9.75e-05	CcSEcCtD
Vigabatrin—Constipation—Topiramate—epilepsy syndrome	1.55e-05	9.73e-05	CcSEcCtD
Vigabatrin—Pain—Topiramate—epilepsy syndrome	1.55e-05	9.73e-05	CcSEcCtD
Vigabatrin—Asthenia—Gabapentin—epilepsy syndrome	1.54e-05	9.7e-05	CcSEcCtD
Vigabatrin—Nausea—Valproic Acid—epilepsy syndrome	1.54e-05	9.69e-05	CcSEcCtD
Vigabatrin—Pruritus—Gabapentin—epilepsy syndrome	1.52e-05	9.57e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.52e-05	0.000158	CbGpPWpGaD
Vigabatrin—Vomiting—Pregabalin—epilepsy syndrome	1.49e-05	9.38e-05	CcSEcCtD
Vigabatrin—Feeling abnormal—Topiramate—epilepsy syndrome	1.49e-05	9.38e-05	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.48e-05	9.3e-05	CcSEcCtD
Vigabatrin—Rash—Pregabalin—epilepsy syndrome	1.48e-05	9.3e-05	CcSEcCtD
Vigabatrin—Dermatitis—Pregabalin—epilepsy syndrome	1.48e-05	9.29e-05	CcSEcCtD
Vigabatrin—Diarrhoea—Gabapentin—epilepsy syndrome	1.47e-05	9.25e-05	CcSEcCtD
Vigabatrin—Headache—Pregabalin—epilepsy syndrome	1.47e-05	9.24e-05	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.47e-05	0.000153	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TSC1—epilepsy syndrome	1.46e-05	0.000153	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTK2B—epilepsy syndrome	1.46e-05	0.000153	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AGT—epilepsy syndrome	1.44e-05	0.00015	CbGpPWpGaD
Vigabatrin—Urticaria—Topiramate—epilepsy syndrome	1.44e-05	9.04e-05	CcSEcCtD
Vigabatrin—Body temperature increased—Topiramate—epilepsy syndrome	1.43e-05	9e-05	CcSEcCtD
Vigabatrin—Abdominal pain—Topiramate—epilepsy syndrome	1.43e-05	9e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CCR2—epilepsy syndrome	1.42e-05	0.000148	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NTRK2—epilepsy syndrome	1.42e-05	0.000148	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SST—epilepsy syndrome	1.42e-05	0.000148	CbGpPWpGaD
Vigabatrin—Dizziness—Gabapentin—epilepsy syndrome	1.42e-05	8.94e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—DUSP6—epilepsy syndrome	1.41e-05	0.000147	CbGpPWpGaD
Vigabatrin—Nausea—Pregabalin—epilepsy syndrome	1.39e-05	8.76e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.39e-05	0.000145	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLAT—epilepsy syndrome	1.39e-05	0.000145	CbGpPWpGaD
Vigabatrin—Vomiting—Gabapentin—epilepsy syndrome	1.37e-05	8.6e-05	CcSEcCtD
Vigabatrin—Rash—Gabapentin—epilepsy syndrome	1.36e-05	8.53e-05	CcSEcCtD
Vigabatrin—Dermatitis—Gabapentin—epilepsy syndrome	1.35e-05	8.52e-05	CcSEcCtD
Vigabatrin—Headache—Gabapentin—epilepsy syndrome	1.35e-05	8.47e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.34e-05	0.00014	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.34e-05	0.00014	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—POMC—epilepsy syndrome	1.33e-05	0.000139	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Topiramate—epilepsy syndrome	1.33e-05	8.38e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.33e-05	0.000139	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.33e-05	0.000138	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—JUNB—epilepsy syndrome	1.31e-05	0.000137	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CNR1—epilepsy syndrome	1.31e-05	0.000137	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.31e-05	0.000136	CbGpPWpGaD
Vigabatrin—Asthenia—Topiramate—epilepsy syndrome	1.3e-05	8.16e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HTR7—epilepsy syndrome	1.28e-05	0.000134	CbGpPWpGaD
Vigabatrin—Pruritus—Topiramate—epilepsy syndrome	1.28e-05	8.05e-05	CcSEcCtD
Vigabatrin—Nausea—Gabapentin—epilepsy syndrome	1.28e-05	8.03e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HBEGF—epilepsy syndrome	1.24e-05	0.00013	CbGpPWpGaD
Vigabatrin—Diarrhoea—Topiramate—epilepsy syndrome	1.24e-05	7.79e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—AKT3—epilepsy syndrome	1.22e-05	0.000127	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—POMC—epilepsy syndrome	1.21e-05	0.000127	CbGpPWpGaD
Vigabatrin—Dizziness—Topiramate—epilepsy syndrome	1.2e-05	7.52e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ADAM10—epilepsy syndrome	1.19e-05	0.000124	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL2—epilepsy syndrome	1.19e-05	0.000124	CbGpPWpGaD
Vigabatrin—Vomiting—Topiramate—epilepsy syndrome	1.15e-05	7.24e-05	CcSEcCtD
Vigabatrin—Rash—Topiramate—epilepsy syndrome	1.14e-05	7.17e-05	CcSEcCtD
Vigabatrin—Dermatitis—Topiramate—epilepsy syndrome	1.14e-05	7.17e-05	CcSEcCtD
Vigabatrin—Headache—Topiramate—epilepsy syndrome	1.13e-05	7.13e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—S100B—epilepsy syndrome	1.13e-05	0.000118	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SOCS3—epilepsy syndrome	1.12e-05	0.000116	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDC42—epilepsy syndrome	1.11e-05	0.000116	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AVP—epilepsy syndrome	1.08e-05	0.000112	CbGpPWpGaD
Vigabatrin—Nausea—Topiramate—epilepsy syndrome	1.07e-05	6.76e-05	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HES1—epilepsy syndrome	1.02e-05	0.000106	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FYN—epilepsy syndrome	9.91e-06	0.000103	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—H2AFX—epilepsy syndrome	9.87e-06	0.000103	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MEF2C—epilepsy syndrome	9.85e-06	0.000103	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.52e-06	9.94e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NGF—epilepsy syndrome	9.42e-06	9.83e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR5—epilepsy syndrome	9.16e-06	9.57e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HTR2A—epilepsy syndrome	8.96e-06	9.36e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TSC2—epilepsy syndrome	8.52e-06	8.89e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGT—epilepsy syndrome	8.51e-06	8.88e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOE—epilepsy syndrome	8.33e-06	8.7e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KDR—epilepsy syndrome	8.17e-06	8.53e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKCB—epilepsy syndrome	7.86e-06	8.21e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6ST—epilepsy syndrome	7.83e-06	8.17e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—POMC—epilepsy syndrome	7.16e-06	7.48e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL2—epilepsy syndrome	7.01e-06	7.31e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FGF2—epilepsy syndrome	6.33e-06	6.61e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RELA—epilepsy syndrome	5.88e-06	6.14e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MTOR—epilepsy syndrome	5.76e-06	6.02e-05	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.35e-06	5.59e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASP3—epilepsy syndrome	5.3e-06	5.54e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—JUN—epilepsy syndrome	5.15e-06	5.38e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—epilepsy syndrome	5.01e-06	5.23e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT1—epilepsy syndrome	4.86e-06	5.07e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SRC—epilepsy syndrome	4.62e-06	4.82e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—epilepsy syndrome	4.5e-06	4.7e-05	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT1—epilepsy syndrome	2.87e-06	3e-05	CbGpPWpGaD
